(Q24185849)

1

0 references

Mohamed A Youssef

2

0 references

Reuben Olugbenga Ayeleke

3

0 references

Julie Brown

4

0 references

Wai Sun Lam

Cochrane Database of Systematic Reviews

5

0 references

publication date

29 April 2016

0 references

published in

0 references

cites work

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of mild stimulation and conventional stimulation in ART outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH agonist versus GnRH antagonist in IVF/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

"Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of follicular fluid and serum cytokine concentrations in women undergoing assisted reproductive treatment with GnRH agonist long and antagonist protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Efficiency of antagonist IVF cycle programming by estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Are GnRH antagonists comparable to agonists for use in IVF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Gonadotrophin-releasing hormone antagonists for assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoingin vitrofertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Gonadotrophin-releasing hormone antagonists for assisted conception.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Thromboembolic phenomena after ovarian stimulation with human gonadotrophins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Ovarian hyperstimulation syndrome: an update review.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Diagnosis, prevention and management of ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021

Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001750.PUB4

7 January 2021